Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Inhibition of epithelial sodium channels by respiratory syncytial virus in vitro and in vivo.

Song W, Wei S, Matalon S.

Ann N Y Acad Sci. 2010 Aug;1203:79-84. doi: 10.1111/j.1749-6632.2010.05560.x. Review.

PMID:
20716287
2.

Inhibition of Na+ transport in lung epithelial cells by respiratory syncytial virus infection.

Chen L, Song W, Davis IC, Shrestha K, Schwiebert E, Sullender WM, Matalon S.

Am J Respir Cell Mol Biol. 2009 May;40(5):588-600. doi: 10.1165/rcmb.2008-0034OC. Epub 2008 Oct 23.

3.

Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.

Davis IC, Lazarowski ER, Hickman-Davis JM, Fortenberry JA, Chen FP, Zhao X, Sorscher E, Graves LM, Sullender WM, Matalon S.

Am J Respir Crit Care Med. 2006 Mar 15;173(6):673-82. Epub 2005 Dec 30.

4.

Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.

Davis IC, Lazarowski ER, Chen FP, Hickman-Davis JM, Sullender WM, Matalon S.

Am J Respir Cell Mol Biol. 2007 Oct;37(4):379-86. Epub 2007 May 31.

5.

Respiratory syncytial virus inhibits lung epithelial Na+ channels by up-regulating inducible nitric-oxide synthase.

Song W, Liu G, Bosworth CA, Walker JR, Megaw GA, Lazrak A, Abraham E, Sullender WM, Matalon S.

J Biol Chem. 2009 Mar 13;284(11):7294-306. doi: 10.1074/jbc.M806816200. Epub 2009 Jan 8.

6.

Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection.

Davis IC, Sullender WM, Hickman-Davis JM, Lindsey JR, Matalon S.

Am J Physiol Lung Cell Mol Physiol. 2004 Jan;286(1):L112-20. Epub 2003 Aug 29.

7.

Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice.

Aeffner F, Traylor ZP, Yu EN, Davis IC.

Am J Physiol Lung Cell Mol Physiol. 2011 Jul;301(1):L99-L109. doi: 10.1152/ajplung.00398.2010. Epub 2011 Apr 8.

8.

Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivo.

Davis IC, Xu A, Gao Z, Hickman-Davis JM, Factor P, Sullender WM, Matalon S.

Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L281-9. Epub 2007 Apr 13.

9.

Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection.

Empey KM, Orend JG, Peebles RS Jr, EgaƱa L, Norris KA, Oury TD, Kolls JK.

PLoS One. 2012;7(7):e40499. doi: 10.1371/journal.pone.0040499. Epub 2012 Jul 6.

10.

Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.

Haeberle HA, Kuziel WA, Dieterich HJ, Casola A, Gatalica Z, Garofalo RP.

J Virol. 2001 Jan;75(2):878-90.

11.

Bioenergetics of murine lungs infected with respiratory syncytial virus.

Alsuwaidi AR, Benedict S, Kochiyil J, Mustafa F, Hartwig SM, Almarzooqi S, Albawardi A, Rizvi TA, Varga SM, Souid AK.

Virol J. 2013 Jan 15;10:22. doi: 10.1186/1743-422X-10-22.

12.

An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.

Kong X, Hellermann GR, Patton G, Kumar M, Behera A, Randall TS, Zhang J, Lockey RF, Mohapatra SS.

Virol J. 2005 Feb 8;2:3.

13.

The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.

Stokes KL, Currier MG, Sakamoto K, Lee S, Collins PL, Plemper RK, Moore ML.

J Virol. 2013 Sep;87(18):10070-82. doi: 10.1128/JVI.01347-13. Epub 2013 Jul 10.

14.

Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection.

Kolli D, Gupta MR, Sbrana E, Velayutham TS, Chao H, Casola A, Garofalo RP.

Am J Respir Cell Mol Biol. 2014 Oct;51(4):502-15. doi: 10.1165/rcmb.2013-0414OC.

15.

Increased susceptibility to RSV infection by exposure to inhaled diesel engine emissions.

Harrod KS, Jaramillo RJ, Rosenberger CL, Wang SZ, Berger JA, McDonald JD, Reed MD.

Am J Respir Cell Mol Biol. 2003 Apr;28(4):451-63.

PMID:
12654634
16.

Suppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species.

Ren K, Lv Y, Zhuo Y, Chen C, Shi H, Guo L, Yang G, Hou Y, Tan RX, Li E.

J Virol. 2016 Jul 27;90(16):7313-22. doi: 10.1128/JVI.00563-16. Print 2016 Aug 15.

17.

Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response.

Hoffman SJ, Laham FR, Polack FP.

Microbes Infect. 2004 Jul;6(8):767-72. Review.

PMID:
15207824
18.

Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression.

Lambert AL, Mangum JB, DeLorme MP, Everitt JI.

Toxicol Sci. 2003 Apr;72(2):339-46. Epub 2003 Mar 7.

PMID:
12655033
19.

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.

De Baets S, Schepens B, Sedeyn K, Schotsaert M, Roose K, Bogaert P, Fiers W, Saelens X.

J Virol. 2013 Mar;87(6):3314-23. doi: 10.1128/JVI.03019-12. Epub 2013 Jan 9.

20.

Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants.

Papin JF, Wolf RF, Kosanke SD, Jenkins JD, Moore SN, Anderson MP, Welliver RC Sr.

Am J Physiol Lung Cell Mol Physiol. 2013 Apr 15;304(8):L530-9. doi: 10.1152/ajplung.00173.2012. Epub 2013 Feb 15.

Supplemental Content

Support Center